Management of hydrocephalus in children with medulloblastoma: Prognostic factors for shunting

Mark Lee, Jeffrey H. Wisoff, Ira Richmond Abbott, III, Diana Freed, Fred J. Epstein

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Patients with medulloblastoma frequently present with hydrocephalus. While not all patients with medulloblastoma will continue to suffer from hydrocephalus after tumor resection, there is a significant proportion who will require a permanent shunt. We have retrospectively reviewed a group of children with medulloblastoma not shunted preoperatively, and have identified several characteristics which are associated with a requirement for permanent shunt. We studied 42 patients and found that 17 patients (40%) required permanent shunts within 4 weeks of craniotomy. The shunted patients were younger (5.4 ± 2.9 vs. 10.0 ± 5.7 years; p < 0.01), had larger ventricles (p < 0.05), and had more extensive tumors (Chang’s stage T3 and T4; p < 0.01). These variables were all independently significant. In addition, we found that the patients requiring postcraniotomy shunts had a much higher rate of morbidity including a postoperative pseudobulbar syndrome. Of interest, we found that none of our patients without the above characteristics required a shunt. In particular, we found that no patient older than 10 years required a shunt. Thus, we conclude that younger patients with moderate to severe preoperative hydrocephalus and extensive tumors may benefit from perioperative CSF diversion. Other patients not meeting the above criteria can probably be safely managed with perioperative corticosteroids alone.

Original languageEnglish (US)
Pages (from-to)240-247
Number of pages8
JournalPediatric Neurosurgery
Volume20
Issue number4
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Medulloblastoma
Hydrocephalus
Pseudobulbar Palsy
Neoplasms
Craniotomy
Adrenal Cortex Hormones
Morbidity

Keywords

  • Complications
  • Hydrocephalus
  • Medulloblastoma
  • Posterior fossa tumors
  • Postoperative
  • Primitive neuroectodermal tumor
  • Pseudobulbar palsy
  • Shunt

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

Management of hydrocephalus in children with medulloblastoma : Prognostic factors for shunting. / Lee, Mark; Wisoff, Jeffrey H.; Abbott, III, Ira Richmond; Freed, Diana; Epstein, Fred J.

In: Pediatric Neurosurgery, Vol. 20, No. 4, 1994, p. 240-247.

Research output: Contribution to journalArticle

Lee, Mark ; Wisoff, Jeffrey H. ; Abbott, III, Ira Richmond ; Freed, Diana ; Epstein, Fred J. / Management of hydrocephalus in children with medulloblastoma : Prognostic factors for shunting. In: Pediatric Neurosurgery. 1994 ; Vol. 20, No. 4. pp. 240-247.
@article{b25ccde40bc049f4ae0a2880f2cfa06b,
title = "Management of hydrocephalus in children with medulloblastoma: Prognostic factors for shunting",
abstract = "Patients with medulloblastoma frequently present with hydrocephalus. While not all patients with medulloblastoma will continue to suffer from hydrocephalus after tumor resection, there is a significant proportion who will require a permanent shunt. We have retrospectively reviewed a group of children with medulloblastoma not shunted preoperatively, and have identified several characteristics which are associated with a requirement for permanent shunt. We studied 42 patients and found that 17 patients (40{\%}) required permanent shunts within 4 weeks of craniotomy. The shunted patients were younger (5.4 ± 2.9 vs. 10.0 ± 5.7 years; p < 0.01), had larger ventricles (p < 0.05), and had more extensive tumors (Chang’s stage T3 and T4; p < 0.01). These variables were all independently significant. In addition, we found that the patients requiring postcraniotomy shunts had a much higher rate of morbidity including a postoperative pseudobulbar syndrome. Of interest, we found that none of our patients without the above characteristics required a shunt. In particular, we found that no patient older than 10 years required a shunt. Thus, we conclude that younger patients with moderate to severe preoperative hydrocephalus and extensive tumors may benefit from perioperative CSF diversion. Other patients not meeting the above criteria can probably be safely managed with perioperative corticosteroids alone.",
keywords = "Complications, Hydrocephalus, Medulloblastoma, Posterior fossa tumors, Postoperative, Primitive neuroectodermal tumor, Pseudobulbar palsy, Shunt",
author = "Mark Lee and Wisoff, {Jeffrey H.} and {Abbott, III}, {Ira Richmond} and Diana Freed and Epstein, {Fred J.}",
year = "1994",
doi = "10.1159/000120797",
language = "English (US)",
volume = "20",
pages = "240--247",
journal = "Pediatric Neurosurgery",
issn = "1016-2291",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Management of hydrocephalus in children with medulloblastoma

T2 - Prognostic factors for shunting

AU - Lee, Mark

AU - Wisoff, Jeffrey H.

AU - Abbott, III, Ira Richmond

AU - Freed, Diana

AU - Epstein, Fred J.

PY - 1994

Y1 - 1994

N2 - Patients with medulloblastoma frequently present with hydrocephalus. While not all patients with medulloblastoma will continue to suffer from hydrocephalus after tumor resection, there is a significant proportion who will require a permanent shunt. We have retrospectively reviewed a group of children with medulloblastoma not shunted preoperatively, and have identified several characteristics which are associated with a requirement for permanent shunt. We studied 42 patients and found that 17 patients (40%) required permanent shunts within 4 weeks of craniotomy. The shunted patients were younger (5.4 ± 2.9 vs. 10.0 ± 5.7 years; p < 0.01), had larger ventricles (p < 0.05), and had more extensive tumors (Chang’s stage T3 and T4; p < 0.01). These variables were all independently significant. In addition, we found that the patients requiring postcraniotomy shunts had a much higher rate of morbidity including a postoperative pseudobulbar syndrome. Of interest, we found that none of our patients without the above characteristics required a shunt. In particular, we found that no patient older than 10 years required a shunt. Thus, we conclude that younger patients with moderate to severe preoperative hydrocephalus and extensive tumors may benefit from perioperative CSF diversion. Other patients not meeting the above criteria can probably be safely managed with perioperative corticosteroids alone.

AB - Patients with medulloblastoma frequently present with hydrocephalus. While not all patients with medulloblastoma will continue to suffer from hydrocephalus after tumor resection, there is a significant proportion who will require a permanent shunt. We have retrospectively reviewed a group of children with medulloblastoma not shunted preoperatively, and have identified several characteristics which are associated with a requirement for permanent shunt. We studied 42 patients and found that 17 patients (40%) required permanent shunts within 4 weeks of craniotomy. The shunted patients were younger (5.4 ± 2.9 vs. 10.0 ± 5.7 years; p < 0.01), had larger ventricles (p < 0.05), and had more extensive tumors (Chang’s stage T3 and T4; p < 0.01). These variables were all independently significant. In addition, we found that the patients requiring postcraniotomy shunts had a much higher rate of morbidity including a postoperative pseudobulbar syndrome. Of interest, we found that none of our patients without the above characteristics required a shunt. In particular, we found that no patient older than 10 years required a shunt. Thus, we conclude that younger patients with moderate to severe preoperative hydrocephalus and extensive tumors may benefit from perioperative CSF diversion. Other patients not meeting the above criteria can probably be safely managed with perioperative corticosteroids alone.

KW - Complications

KW - Hydrocephalus

KW - Medulloblastoma

KW - Posterior fossa tumors

KW - Postoperative

KW - Primitive neuroectodermal tumor

KW - Pseudobulbar palsy

KW - Shunt

UR - http://www.scopus.com/inward/record.url?scp=0028343071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028343071&partnerID=8YFLogxK

U2 - 10.1159/000120797

DO - 10.1159/000120797

M3 - Article

C2 - 8043462

AN - SCOPUS:0028343071

VL - 20

SP - 240

EP - 247

JO - Pediatric Neurosurgery

JF - Pediatric Neurosurgery

SN - 1016-2291

IS - 4

ER -